Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Global Market Report 2025

Global Cell And Gene Therapy Contract Development And Manufacturing Organization CDMO Market Report 2024

Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Global Market Report 2025 – By Product Type (Gene Therapy, Gene-Modified Cell Therapy, Cell Therapy), By Phase (Phase 1, Phase 2, Phase 3, Phase 4), By Indication (Oncology, Infectious Diseases, Neurological Disorders, Rare Diseases, Other Indications) – Market Size, Trends, And Global Forecast 2025-2034

Name: Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Global Market Report 2025
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Global Market Report 2025

Report Price : $4490.00 | Pages : 175 | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Global Market Report 2025

Proud Members Of

Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Definition

A cell and gene therapy contract development and manufacturing organization (CDMO) is a specialized company that provides services to support the development, manufacturing, and commercialization of cell-based and gene therapy products. These organizations offer services tailored to the unique needs of companies developing advanced therapies, including biopharmaceutical companies, academic institutions, and government agencies. Cell and gene therapy CDMOs play a critical role in accelerating the development and commercialization of advanced therapy products by offering specialized expertise, infrastructure, and services to support their clients' needs from early-stage development through commercialization.

The main product types of cell and gene therapy contract development and manufacturing organization (CDMO) are gene therapy, gene-modified cell therapy, and cell therapy. Gene therapy involves modifying or manipulating the genes within a person's cells to treat or prevent disease. Various phases include phase 1, phase 2, phase 3, and phase 4 for different indications, such as oncology, infectious diseases, neurological disorders, rare diseases, and others.

Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Segmentation

The cell and gene therapy contract development and manufacturing organization (CDMO) market covered in this report is segmented –

1) By Product Type: Gene Therapy, Gene-Modified Cell Therapy, Cell Therapy

2) By Phase: Phase 1, Phase 2, Phase 3, Phase 4

3) By Indication: Oncology, Infectious Diseases, Neurological Disorders, Rare Diseases, Other Indications

Subsegments:

1) By Gene Therapy: Viral Vector-Based Gene Therapy, Non-Viral Gene Therapy, Plasmid DNA-Based Gene Therapy

2) By Gene-Modified Cell Therapy: CAR-T Cell Therapy, TCR-T Cell Therapy, NK Cell Therapy

3) By Cell Therapy: Stem Cell Therapy, Progenitor Cell Therapy, Immune Cell Therapy

Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Size and growth rate 2025 to 2029: Graph

Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Size 2025 And Growth Rate

The cell and gene therapy contract development and manufacturing organization (CDMO) market size has grown exponentially in recent years. It will grow from $5.41 billion in 2024 to $6.94 billion in 2025 at a compound annual growth rate (CAGR) of 28.2%. The growth in the historic period can be attributed to increased technological advancements, favorable regulatory frameworks, increased investment, high prevalence of genetic disorders, and an increased number of strategic partnerships.

Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Growth Forecast

The cell and gene therapy contract development and manufacturing organization (CDMO) market size is expected to see exponential growth in the next few years. It will grow to $18.54 billion in 2029 at a compound annual growth rate (CAGR) of 27.8%. The growth in the forecast period can be attributed to expanded therapeutic applications, regulatory evolution, increased investment, technological innovations, and global collaboration. Major trends in the forecast period include increased demand for personalized therapies, growth in automation and digitalization, expansion of manufacturing capacities, emergence of novel delivery systems, and heightened focus on sustainability and environmental impact.

Book your 30 minutes free consultation with our research experts

Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Driver: Rising Cancer Rates Drive Growth In Cell And Gene Therapy CDMO Market

The growing prevalence of cancer cases is expected to propel the growth of the cell and gene therapy contract development and manufacturing organization (CDMO) market going forward. Cancer is a group of diseases characterized by uncontrolled growth and spread of abnormal cells in the body. The growing prevalence of cancer cases is due to aging populations, lifestyle changes, environmental exposures, and improved detection methods. Cell and gene therapy contract development and manufacturing organization (CDMO) helps reduce cancer prevalence by developing and manufacturing innovative, targeted treatments that enhance efficacy and patient outcomes. For instance, in October 2022, according to Macmillan Cancer Support, a UK-based charitable organization, the estimated number of people living with cancer in the UK is projected to increase from 3 million in 2022 to 3.5 million by 2025, 4 million by 2030, and 5.3 million by 2040. Therefore, the growing prevalence of cancer cases drives the growth of the cell and gene therapy contract development and manufacturing organization (CDMO) market.

Global Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Major Players

Major companies operating in the cell and gene therapy contract development and manufacturing organization (CDMO) market are Pfizer Inc., Merck & Co. Inc., Thermo Fisher Scientific Inc., Novartis AG, FUJIFILM Diosynth Biotechnologies, AGC Biologics, Ajinomoto Co Inc., Lonza Group, Catalent Inc., Charles River Laboratories International Inc., Sartorius Stedim Biotech, Samsung Biologics Co Ltd., WuXi Biologics, Recipharm AB, Almac Group Ltd., KBI Biopharma, Rentschler Biopharma, Bio Elpida, Oxford BioMedica Plc, Avid Bioservices Inc., Cell and Gene Therapy Catapult, VGXI Inc., Genezen Laboratories Inc., Pluri Inc., OmniaBio Inc.

Global Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Trend: Advancements In Cell And Gene Therapy Manufacturing

Major companies operating in the cell and gene therapy contract development and manufacturing organization (CDMO) market are focused on expanding their portfolio with advanced solutions such as PluriMatrix technology to enhance the scalability, efficiency, and quality of cell-based product manufacturing. PluriMatrix technology is a proprietary system tailored for the large-scale production of cell-based products. This advanced technology facilitates the 3D expansion of cells on an industrial scale, ensuring high yield and consistent quality through an automated, fully controlled, and validated process. For instance, in January 2024, Pluri, an Israel-based biotech company, launched PluriCDMO, a new business division that offers cell therapy manufacturing services as a contract development and manufacturing organization (CDMO). The new division includes a 47,000-square-foot good manufacturing practice (GMP) cell therapy production facility. Pluri's newly established division offers end-to-end services from early preclinical stages to late-stage clinical trials and commercialization, covering process and analytical development, scale-up, validation, logistics, automation, and regulatory-approved comparability studies, as detailed in a company announcement. It leverages the company's cutting-edge PluriMatrix technology to offer advanced cell therapy manufacturing services.

Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Merger And Acquisition: Ajinomoto Co. Inc. Boosts Gene Therapy Manufacturing With Forge Biologics Acquisition

In November 2023, Ajinomoto Co. Inc., a Japan-based food and biotechnology corporation, acquired Forge Biologics for $620 million. Through this acquisition, Ajinomoto bolsters its global capabilities in adeno-associated virus (AAV) and plasmid gene therapy manufacturing, enriching and fortifying its existing contract development and manufacturing services. Forge Biologics is a US-based gene therapy contract development and manufacturing organization (CDMO) and clinical-stage therapeutics company.

Regional Outlook For The Global Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market

North America was the largest region in the cell and gene therapy contract development and manufacturing organization (CDMO) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell and gene therapy contract development and manufacturing organization (CDMO) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the cell and gene therapy contract development and manufacturing organization (CDMO) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market?

The cell and gene therapy contract development and manufacturing organization (CDMO) market includes revenues earned by contract development and manufacturing organizations providing services for the development, manufacturing, and testing of cell and gene therapy products. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Industry?

The cell and gene therapy contract development and manufacturing organization (CDMO) market research report is one of a series of new reports from The Business Research Company that provides cell and gene therapy contract development and manufacturing organization (CDMO) market statistics, including cell and gene therapy contract development and manufacturing organization (CDMO) industry global market size, regional shares, competitors with a cell and gene therapy contract development and manufacturing organization (CDMO) market share, detailed cell and gene therapy contract development and manufacturing organization (CDMO) market segments, market trends, and opportunities, and any further data you may need to thrive in the cell and gene therapy contract development and manufacturing organization (CDMO) industry. This cell and gene therapy contract development and manufacturing organization (CDMO) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$6.94 billion
Revenue Forecast In 2034	$18.54 billion
Growth Rate	CAGR of 27.8% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	1) By Product Type: Gene Therapy, Gene-Modified Cell Therapy, Cell Therapy 2) By Phase: Phase 1, Phase 2, Phase 3, Phase 4 3) By Indication: Oncology, Infectious Diseases, Neurological Disorders, Rare Diseases, Other Indications Subsegments: 1) By Gene Therapy: Viral Vector-Based Gene Therapy, Non-Viral Gene Therapy, Plasmid DNA-Based Gene Therapy 2) By Gene-Modified Cell Therapy: CAR-T Cell Therapy, TCR-T Cell Therapy, NK Cell Therapy 3) By Cell Therapy: Stem Cell Therapy, Progenitor Cell Therapy, Immune Cell Therapy
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Pfizer Inc, Merck & Co. Inc., Thermo Fisher Scientific Inc, Novartis AG, FUJIFILM Diosynth Biotechnologies, AGC Biologics, Ajinomoto Co Inc, Lonza Group, Catalent Inc, Charles River Laboratories International Inc, Sartorius Stedim Biotech, Samsung Biologics Co Ltd, WuXi Biologics, Recipharm AB, Almac Group Ltd, KBI Biopharma, Rentschler Biopharma, Bio Elpida, Oxford BioMedica Plc, Avid Bioservices Inc, Cell and Gene Therapy Catapult, VGXI Inc, Genezen Laboratories Inc., Pluri Inc., OmniaBio Inc.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Characteristics

3. Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Trends And Strategies

4. Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Growth Analysis And Strategic Analysis Framework

5.1. Global Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Growth Rate Analysis

5.4. Global Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Total Addressable Market (TAM)

6. Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Segmentation

6.1. Global Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Gene Therapy

Gene-Modified Cell Therapy

Cell Therapy

6.2. Global Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Phase 1

Phase 2

Phase 3

Phase 4

6.3. Global Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oncology

Infectious Diseases

Neurological Disorders

Rare Diseases

Other Indications

6.4. Global Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Sub-Segmentation Of Gene Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Viral Vector-Based Gene Therapy

Non-Viral Gene Therapy

Plasmid DNA-Based Gene Therapy

6.5. Global Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Sub-Segmentation Of Gene-Modified Cell Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

CAR-T Cell Therapy

TCR-T Cell Therapy

NK Cell Therapy

6.6. Global Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Sub-Segmentation Of Cell Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Stem Cell Therapy

Progenitor Cell Therapy

Immune Cell Therapy

7. Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Regional And Country Analysis

7.1. Global Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market

8.1. Asia-Pacific Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market

9.1. China Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Overview

9.2. China Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market

10.1. India Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market

11.1. Japan Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Overview

11.2. Japan Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market

12.1. Australia Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market

13.1. Indonesia Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market

14.1. South Korea Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Overview

14.2. South Korea Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market

15.1. Western Europe Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Overview

15.2. Western Europe Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market

16.1. UK Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market

17.1. Germany Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market

18.1. France Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market

19.1. Italy Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market

20.1. Spain Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market

21.1. Eastern Europe Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Overview

21.2. Eastern Europe Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market

22.1. Russia Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market

23.1. North America Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Overview

23.2. North America Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market

24.1. USA Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Overview

24.2. USA Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market

25.1. Canada Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Overview

25.2. Canada Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market

26.1. South America Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Overview

26.2. South America Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market

27.1. Brazil Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market

28.1. Middle East Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Overview

28.2. Middle East Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market

29.1. Africa Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Overview

29.2. Africa Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Competitive Landscape And Company Profiles

30.1. Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Competitive Landscape

30.2. Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Company Profiles

30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

30.2.5. FUJIFILM Diosynth Biotechnologies Overview, Products and Services, Strategy and Financial Analysis

31. Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Other Major And Innovative Companies

31.1. AGC Biologics

31.2. Ajinomoto Co Inc.

31.3. Lonza Group

31.4. Catalent Inc.

31.5. Charles River Laboratories International Inc.

31.6. Sartorius Stedim Biotech

31.7. Samsung Biologics Co Ltd

31.8. WuXi Biologics

31.9. Recipharm AB

31.10. Almac Group Ltd

31.11. KBI Biopharma

31.12. Rentschler Biopharma

31.13. Bio Elpida

31.14. Oxford BioMedica Plc

31.15. Avid Bioservices Inc.

32. Global Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market

34. Recent Developments In The Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market

35. Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market High Potential Countries, Segments and Strategies

35.1 Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market In 2029 - Countries Offering Most New Opportunities

35.2 Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market In 2029 - Segments Offering Most New Opportunities

35.3 Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Sub-Segmentation Of Gene Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Sub-Segmentation Of Gene-Modified Cell Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Sub-Segmentation Of Cell Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Asia-Pacific, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Asia-Pacific, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Asia-Pacific, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: China, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: China, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: China, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: India, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: India, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: India, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: Japan, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: Japan, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Japan, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Australia, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Australia, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Australia, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Indonesia, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Indonesia, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Indonesia, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: South Korea, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: South Korea, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: South Korea, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: Western Europe, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Western Europe, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Western Europe, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: UK, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: UK, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: UK, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: Germany, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Germany, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Germany, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: France, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: France, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: France, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: Italy, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: Italy, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Italy, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Spain, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Spain, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Spain, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Eastern Europe, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Eastern Europe, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Eastern Europe, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Russia, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Russia, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Russia, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: North America, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: North America, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: North America, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: USA, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: USA, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: USA, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: Canada, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: Canada, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: Canada, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: South America, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: South America, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: South America, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: Brazil, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: Brazil, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Brazil, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Middle East, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Middle East, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Middle East, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Africa, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Africa, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Africa, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Pfizer Inc. Financial Performance

Table 78: Merck & Co. Inc. Financial Performance

Table 79: Thermo Fisher Scientific Inc. Financial Performance

Table 80: Novartis AG Financial Performance

Table 81: FUJIFILM Diosynth Biotechnologies Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Sub-Segmentation Of Gene Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Sub-Segmentation Of Gene-Modified Cell Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Sub-Segmentation Of Cell Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Asia-Pacific, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Asia-Pacific, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Asia-Pacific, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: China, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: China, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: China, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: India, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: India, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: India, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: Japan, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: Japan, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Japan, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Australia, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Australia, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Australia, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Indonesia, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Indonesia, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Indonesia, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: South Korea, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: South Korea, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: South Korea, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: Western Europe, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Western Europe, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Western Europe, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: UK, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: UK, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: UK, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: Germany, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Germany, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Germany, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: France, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: France, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: France, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: Italy, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: Italy, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Italy, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Spain, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Spain, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Spain, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Eastern Europe, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Eastern Europe, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Eastern Europe, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Russia, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Russia, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Russia, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: North America, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: North America, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: North America, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: USA, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: USA, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: USA, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: Canada, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: Canada, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: Canada, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: South America, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: South America, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: South America, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: Brazil, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: Brazil, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Brazil, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Middle East, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Middle East, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Middle East, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Africa, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Africa, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Africa, Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Pfizer Inc. Financial Performance

Figure 78: Merck & Co. Inc. Financial Performance

Figure 79: Thermo Fisher Scientific Inc. Financial Performance

Figure 80: Novartis AG Financial Performance

Figure 81: FUJIFILM Diosynth Biotechnologies Financial Performance

Forecasting Till 2030: Opportunities And Strategies In The Global Value Based Care Payment Market – Includes Value Based Care Payment Market Analysis

How Will The Nuclear Medicine Market Grow In 2022?

What Is The Pediatric Imaging Market Overview In 2022?

Latest Healthcare Technology Management Market Growth Study 2022-2026 By The Business Research Company

The Business Research Company offers the hospital acquired infection control market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the multiplex assays market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the healthcare it consulting market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the renal biomarkers market research report 2022 with industry size, share, segments and market growth

Cell and Gene Therapy Global Market Report 2025 – By Product (Cell Therapy, Gene Therapy), By Application (Oncology, Neurological Disorders, Other Applications), By End User (Hospitals, Ambulatory Surgical Centers, Cancer Care Centers, Wound Care Centers, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cell And Gene Therapy Supply Chain/Logistics Global Market Report 2025 – By Type Of Software Solution (Cell Orchestration Platform, Enterprise Manufacturing System, Inventory Management System, Laboratory Information Management System, Logistics Management System, Patient Management System, Quality Management System, Tracking And Tracing System), By Mode Of Deployment (Cloud-Based Solution, On-Premises Solution), By Component (Cryogenic Shippers, Cryogenic Storage Freezers, Ultra-Low Freezers, Cold Chain Management Systems, Shipment, Storage Medium, Cryogenic Packout Kits, Other Components), By Application Area (Donor Eligibility Assessment, Sample Collection, Manufacturing, Logistics, Patient Verification, Treatment Follow-Up), By End User (Biobank, Cell Therapy Lab, Hospital, Research Institute, Commercial Organization) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cell Therapy Global Market Report 2025 – By Technique (Stem Cell Therapy, Cell Vaccine, Adoptive Cell Transfer (ACT), Fibroblast Cell Therapy, Chondrocyte Cell Therapy), By Therapy Type (Allogeneic Therapies, Autologous Therapies), By Application (Oncology, Cardiovascular Disease (CVD), Orthopedic, Wound Healing, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Stem Cell Therapy Global Market Report 2025 – By Type (Allogeneic Stem Cell Therapy, Autologous Stem Cell Therapy), By Cell Source (Adult Stem Cells, Induced Pluripotent Stem Cells, Embryonic Stem Cells), By Application (Musculoskeletal Disorders and Wounds & Injuries, Cancer, Autoimmune Disorders, Others), By End-Users (Hospitals And Clinics, Research Centers, Others) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cellular Immunotherapy Global Market Report 2025 – By Therapy (Tumor-Infiltrating Lymphocyte (TIL) Therapy, Engineered T Cell Receptor (TCR) Therapy, Chimeric Antigen Receptor (CAR) T Cell Therapy, Natural Killer (NK) Cell Therapy), By Primary Indication (B-cell Malignancies, Prostate Cancer, Renal Cell Carcinoma, Liver Cancer, Non-Hodgkin lymphoma, Other Primary Indications), By Application (Prostate Cancer, Breast Cancer, Skin Cancer, Ovarian Cancer, Brain Tumor, Lung Cancer, Other Applications ) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cell and Gene Therapy Global Market Report 2025 – By Product (Cell Therapy, Gene Therapy), By Application (Oncology, Neurological Disorders, Other Applications), By End User (Hospitals, Ambulatory Surgical Centers, Cancer Care Centers, Wound Care Centers, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cellular or Mobile Telephone Services Global Market Report 2025 – By Type (Basic Communication, Value-Added), By Service (3G Services, 4G Services, 5G Services), By End User (Manufacturing, Energy And Utilities, Media And Entertainment, It And Telecom, Transportation And Logistics, Healthcare) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cell Therapy Technologies Global Market Report 2025 – By Product (Consumables, Equipment, Systems And Software), By Cell Type (T-Cells, Stem Cells, Other Cells), By Process (Cell Processing, Cell Preservation, Distribution And Handling, Process Monitoring And Quality Control), By End User (Life Science Companies, Research Institutes And Cell Banks) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) market?

How will the Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) market drivers and restraints affect the market dynamics? What forces will shape the Cell And Gene Therapy Contract Development And Manufacturing Organization (C

The Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) market major growth driver - Rising Cancer Rates Drive Growth In Cell And Gene Therapy CDMO Market. For further insights on the Cell And Gene Therapy Contract Development request a sample here

What is the forecast market size or the forecast market value of the Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) market?

The Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) market size has grown strongly in recent years. The cell and gene therapy contract development and manufacturing organization (CDMO) market size has grown exponentially in recent years. It will grow from $5.41 billion in 2024 to $6.94 billion in 2025 at a compound annual growth rate (CAGR) of 28.2%. The growth in the historic period can be attributed to increased technological advancements, favorable regulatory frameworks, increased investment, high prevalence of genetic disorders, and an increased number of strategic partnerships. The cell and gene therapy contract development and manufacturing organization (CDMO) market size is expected to see exponential growth in the next few years. It will grow to $18.54 billion in 2029 at a compound annual growth rate (CAGR) of 27.8%. The growth in the forecast period can be attributed to expanded therapeutic applications, regulatory evolution, increased investment, technological innovations, and global collaboration. Major trends in the forecast period include increased demand for personalized therapies, growth in automation and digitalization, expansion of manufacturing capacities, emergence of novel delivery systems, and heightened focus on sustainability and environmental impact. For further insights on the Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) market, request a sample here

How is the Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) market segmented?

The cell and gene therapy contract development and manufacturing organization (CDMO) market covered in this report is segmented –
1) By Product Type: Gene Therapy, Gene-Modified Cell Therapy, Cell Therapy
2) By Phase: Phase 1, Phase 2, Phase 3, Phase 4
3) By Indication: Oncology, Infectious Diseases, Neurological Disorders, Rare Diseases, Other Indications
Subsegments:
1) By Gene Therapy: Viral Vector-Based Gene Therapy, Non-Viral Gene Therapy, Plasmid DNA-Based Gene Therapy
2) By Gene-Modified Cell Therapy: CAR-T Cell Therapy, TCR-T Cell Therapy, NK Cell Therapy
3) By Cell Therapy: Stem Cell Therapy, Progenitor Cell Therapy, Immune Cell Therapy For further insights on the Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) market, request a sample here

Which region has the largest share of the Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) market? What are the other regions covered in the report?

North America was the largest region in the cell and gene therapy contract development and manufacturing organization (CDMO) market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell and gene therapy contract development and manufacturing organization (CDMO) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. For further insights on the Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) market, request a sample here.

Who are the major players in the Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) market?

What are the key trends in the Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) market?

Major trends in the Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) market include Advancements In Cell And Gene Therapy Manufacturing. For further insights on the Cell And Gene Therapy Contract Development And Manufacturi request a sample here.

What are the major opportunities in the Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) market? What are the strategies for the Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) market?

For detailed insights on the major opportunities and strategies in the Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) market, request a sample here.

How does the Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) market relate to the overall economy and other similar markets?

For detailed insights on Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO)'s relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) industry?

For detailed insights on the mergers and acquisitions in the Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) industry, request a sample here.

What are the key dynamics influencing the Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) market growth? SWOT analysis of the Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) market.

For detailed insights on the key dynamics influencing the Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) market growth and SWOT analysis of the Cell And Gene Therapy Contract Development And Manufacturing Organization (CD request a sample here.